BenzingaOctober 13, 2026 at 1:10 PM NY14 Days Ago
UBS Maintains Buy on CareTrust REIT, Lowers Price Target to $44
UBS analyst Michael Goldsmith maintains CareTrust REIT (NYSE:CTRE) with a Buy and lowers the price target from $48 to $44.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
